Elsevier

Atherosclerosis

Volume 266, November 2017, Pages 31-40
Atherosclerosis

Review article
Epigenetic programming, early life nutrition and the risk of metabolic disease

https://doi.org/10.1016/j.atherosclerosis.2017.09.003Get rights and content

Highlights

  • Adult health and disease are traced to fetal origins and early life factors.

  • Parental diet regulates epigenetic modification and the risk of metabolic disease in offspring.

  • Nutrient sensing of metabolic status and homeostasis is controlled centrally by the hypothalamus.

  • Hypothalamus interpret extracellular cues to control energy balance by regulating epigenetic information and gene expression.

Abstract

Time separates the past from the present, during this period memory are formed - written in code and decoded to be read while other memories are erased - but when it comes to the epigenome some memories are harder to forget than others. Recent studies show chemical information is written in the context of the epigenome and codified on histone and non-histone proteins to regulate nuclear processes such as gene transcription. The genome is also subject to modification in the form of 5-methylcytosine, which has been implicated in metabolic memory. In this review, we examine some of the chemical modifications that signal early life events and explore epigenetic changes that underlie the diabetic vasculature. The fine balance between past and present is discussed, as it pertains to gestational diabetes and obesity in context to the Barker hypothesis. We also examine emerging experimental evidence suggesting the hypothalamus as a central regulator of obesity risk and explore current genomic medicine. As for how cells recall specific chemical information, we examine the experimental evidence implicating chemical cues on the epigenome, providing examples of diet during pregnancy and the increased risk of disease in offspring.

Introduction

The role of epigenetic mechanisms, which involve heritable changes in gene expression that do not involve a change in DNA sequence, are increasingly recognised in the aetiology and progression of human disease. These mechanisms may influence gene expression during both intrauterine and early postnatal developmental periods, predisposing individuals to an obesogenic phenotype that persists throughout adulthood, leading to long term negative metabolic effects and health outcomes. These epigenetic changes could be driven by a host of environmental and lifestyle conditions, including diet and exercise, and may have profound effects on placental development and neurogenesis of hypothalamic body-weight regulation pathways. Likewise, epigenetic changes may be implicated in chronic disease such as diabetes and atherosclerosis, thus explaining the unrelenting progression and accelerated rates of their associated microvascular and macrovascular complications. Recent epidemiological and experimental animal studies demonstrate the importance of early intervention in diabetes, resulting in decreased incidence of future complications despite subsequent poor glycaemic control, suggesting a metabolic memory effect [88]. Furthermore, altered DNA methylation patterns between healthy and non-symptomatic diseased individuals have been retrospectively observed supporting the utility of possible future prognostic epigenetic analyses in healthcare [4]. Moreover, the discovery of an atherosclerotic-specific DNA methylation profile highlights the potential for future therapeutic interventions, which are highly target specific [172]. However, further investigation into the human epigenome is desperately needed to provide significant insight and better understanding of the nature of the molecular mechanisms that underlie these interactions.

Section snippets

Metabolism and memory

The alarming rise of obesity with its associated medical burdens represents a major global public health issue that underpins the importance of elucidating the molecular mechanisms of metabolic disorders [88]. The effects of chronic hyperglycaemia in both type 1 and type 2 diabetes mellitus are strongly associated with the development of macrovascular and microvascular complications including blindness, amputations, heart attacks and strokes, kidney failure and premature mortality [85], [33],

Gestational programming and the Barker hypothesis

The phenomenon of ‘metabolic memory’ is not restricted to short and medium term periods of hyperglycaemia observed in the diabetic patient, but may also have significant consequences in the developing uterine environment, leading to more persistent and long term metabolic effects. Clinical findings from as early as the 1980s showed an increased risk of several chronic health conditions, including diabetes and CVD, in low birth weight individuals, indicating that in utero environment may

High fat diet and the Barker hypothesis

However, metabolic developmental programming is not restricted to undernutrition since recent studies have also implicated maternal low protein and high fat diet (HFD) as drivers shaping future offspring health [156]. The outcomes of maternal HFD in experimental rodent and non-human primate models include poor fetal growth and adverse metabolic events with predisposition to metabolic disease including liver dysfunction, thyroid dysregulation, insulin resistance, high blood pressure and

Gestational diabetes and the Barker hypothesis

Another notable example of the Barker hypothesis is demonstrated by gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance with onset or first recognition during pregnancy [6]. This condition is becoming more common because of increasing levels of obesity, and is present in 3–17% of all pregnancies, depending on the population studied and diagnostic criteria applied [12], [76]. Apart from increased perinatal morbidity and mortality, intrauterine hyperglycaemia is

Assisted reproductive technology induced epigenetic instability

While the fetal, childhood, and adult metabolic perturbations may permanently alter long-term health outcomes, the mammalian epigenome is most plastic in the early stage of embryonic development when parent-specific genome wide reprogramming occurs [110], [130]. In the human preimplantation embryo, paternal genome demethylation and global reprogramming characterizes the early events of fertilization [145]. As increasing numbers of children are being conceived by assisted reproductive technology

Hypothalamus as a central regulator of obesity

Complex polygenic human metabolic disease represented by T2DM is poorly characterized by current monogenic animal models which rely on single gene mutations such as leptin deficiency [92]. Instead, a polygenic animal model where simple dietary modification leads to the development of metabolic syndrome is found in Psammomys obesus (Israeli sand rat) and is useful for studying nutrient restriction and models of obesity [139], [159]. The metabolic changes of high calorie consumption in humans

DNA methylation in human disease

One of the best characterized epigenetic marks is DNA methylation, which is implicated to regulate gene expression and genomic stability, and is influenced by environmental and external factors [80]. Genomic methylation has regulatory roles in a broad range of biological processes including genomic imprinting, cellular differentiation and inflammation [16]. DNA methylation at promotor regions is often inversely correlated with gene expression, whereas in gene bodies and intergenic loci it may

Epigenetic pharmacology

The inherent and potential reversibility of epigenetic mechanisms provides a unique opportunity for therapeutic targeting of human disease. Mutations in genes encoding histone and DNA demethylases as well as chromatin regulating and modifying enzymes are present in the majority of human cancers, resulting in drastically altered DNA and histone methylation patterns [169], [83], [50]. Furthermore, the dysregulation of epigenetic events is emerging as a key factor driving the pathological sequelae

Clinical implications

Although T2DM has long been known to progress despite glucose-lowering treatment [154], in one study nearly 90% of obese individuals with T2DM who underwent bariatric surgery in the 1980's retained normal blood glucose levels after 10 years [124]. A randomized study comparing gastric banding with intensive medical therapy for T2DM showed that the phenomenon of diabetes remission was directly related to the degree of weight loss rather than modality of treatment and was achieved in 73% and 13%

Conclusion

Increasing clinical and experimental evidence indicates that epigenetic processes may underlie the aetiology of chronic disease such as diabetes and atherosclerosis. It is becoming progressively conceivable that aberrant alterations in DNA methylation may occur as soon as a few hours in certain metabolic milieus and persist for much longer, particularly with continued insults. This may explain the pathogenesis of diabetes and its subsequent effects on multiple organs and tissues leading to

Conflict of interest

The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.

Financial support

The authors acknowledge grant and fellowship support from the National Health and Medical Research Council (NHMRC, 0526681, 1048377 and 1113188). This work was supported in part by the Royal College of Pathologists of Australasia Pathology for Medical Schools Scholarship. Supported in part by the Victorian Government's Operational Infrastructure Support Program.

References (179)

  • B.M. King

    The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight

    Physiol. Behav.

    (2006)
  • R.A. Kowluru

    Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats

    J. Diabetes Complicat.

    (2004)
  • The Diabetes Control and Complications Trial Research Group

    The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus

    N. Engl. J. Med.

    (1993)
  • UK Prospective Diabetes Study (UKPDS) Group

    Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

    Lancet

    (1998)
  • Gerstein

    Effects of intensive glucose lowering in type 2 diabetes

    N. Engl. J. Med.

    (2008)
  • E. Agardh

    Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy

    BMC Med.

    (2015)
  • C.E. Aiken et al.

    Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet

    FASEB J.

    (2016)
  • American Diabetes A

    Diagnosis and classification of diabetes mellitus

    Diabetes Care

    (2009)
  • D.J. Barker

    The fetal and infant origins of adult disease

    BMJ

    (1990)
  • C.G. Bell

    Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus

    BMC Med. Genomics

    (2010)
  • A. Ben-Haroush

    Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes

    Diabet. Med.

    (2004)
  • A.M. Binder

    Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex

    Clin. Epigenetics

    (2015)
  • N.K. Binder

    Paternal diet-induced obesity retards early mouse embryo development, mitochondrial activity and pregnancy health

    PLoS One

    (2012)
  • N.K. Binder

    Parental diet-induced obesity leads to retarded early mouse embryo development and altered carbohydrate utilisation by the blastocyst

    Reprod. Fertil. Dev.

    (2012)
  • C. Bock

    Analysing and interpreting DNA methylation data

    Nat. Rev. Genet.

    (2012)
  • T.B. Bodvarsdottir

    Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes

    Diabetologia

    (2010)
  • L. Bouchard

    Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration

    Diabetes

    (2012)
  • L. Bouchard

    Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy

    Diabetes Care

    (2010)
  • D. Brasacchio

    Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail

    Diabetes

    (2009)
  • A. Calle

    Male mice produced by in vitro culture have reduced fertility and transmit organomegaly and glucose intolerance to their male offspring

    Biol. Reprod.

    (2012)
  • M.A. Carless

    Genetic effects on DNA methylation and its potential relevance for obesity in Mexican Americans

    PLoS One

    (2013)
  • J. Chalmers et al.

    UKPDS and the legacy effect

    N. Engl. J. Med.

    (2008)
  • J. Chen

    Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes

    FASEB J.

    (2008)
  • Z. Chen

    Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

    Proc. Natl. Acad. Sci. U. S. A.

    (2016)
  • J.H. Choi

    Trichostatin A attenuates airway inflammation in mouse asthma model

    Clin. Exp. Allergy

    (2005)
  • C.R. Chong

    Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes

    Cardiovasc Drugs Ther.

    (2014)
  • G. Ciriello

    Emerging landscape of oncogenic signatures across human cancers

    Nat. Genet.

    (2013)
  • R. Clarke-Harris

    PGC1alpha promoter methylation in blood at 5-7 years predicts adiposity from 9 to 14 years (EarlyBird 50)

    Diabetes

    (2014)
  • P.A. Cleary

    The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

    Diabetes

    (2006)
  • M.E. Cooper et al.

    Epigenetics: mechanisms and implications for diabetic complications

    Circ. Res.

    (2010)
  • R.B. D'Agostino

    Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

    Diabetes Care

    (2004)
  • L.M. Delahanty

    Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program

    Diabetes Care

    (2012)
  • J. Denham

    Genome-wide sperm DNA methylation changes after 3 months of exercise training in humans

    Epigenomics

    (2015)
  • J.B. Dixon

    Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

    JAMA

    (2008)
  • W. Duckworth

    Glucose control and vascular complications in veterans with type 2 diabetes

    N. Engl. J. Med.

    (2009)
  • J.C. Dumoulin

    Effect of in vitro culture of human embryos on birthweight of newborns

    Hum. Reprod.

    (2010)
  • A. El-Osta

    Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

    J. Exp. Med.

    (2008)
  • N. El Hajj

    Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus

    Diabetes

    (2013)
  • R.L. Engerman et al.

    Progression of incipient diabetic retinopathy during good glycemic control

    Diabetes

    (1987)
  • F. Fang

    Decitabine reactivated pathways in platinum resistant ovarian cancer

    Oncotarget

    (2014)
  • Cited by (76)

    • Impact of the exposome on the development and function of pancreatic β-cells

      2022, Molecular Aspects of Medicine
      Citation Excerpt :

      However environmental factors, such as viral infections (coxsackie and adenovirus) or stress, can trigger T1D in those at risk. One environmental stressor is size at birth, as both small and large babies can be programmed through epigenetic modification of gene expression levels to be more susceptible to immune diseases postnatally (Block and El-Osta, 2017). While metabolic diseases often have a basis in alterations to the innate immune system leading to an enhanced basal inflammatory state within the tissues, exposomal stressors in utero can also program an increased risk for autoimmune diseases based on the generation of cytotoxic T cells recognizing self-antigens, as in T1D (Chen et al., 2016).

    • The influence of TERC, TERT and ACYP2 genes polymorphisms on plasma telomerase concentration, telomeres length and T2DM

      2021, Gene
      Citation Excerpt :

      More than 200 genetic loci were found to be related to T2DM including those involved in metabolism of glucose, proteins and lipids, and insulin secretion, action and regulation, inflammatory pathways and mitochondrial function (Lin and Sun, 2010; Brunetti et al., 2014). Several environmental factors were also found to influence the path of T2DM via epigenetics e.g. by methylation (Block and El-Osta, 2017). Abnormal telomeres attrition was emerged as a molecular marker and pathophysiological factor in T2DM and several studies were reported the association of telomeres shortening with T2DM (Jeanclos et al., 1998; Zee et al., 2010, Zhao et al., 2013; Willeit et al., 2014).

    View all citing articles on Scopus
    View full text